Two reads this week.
The first from Hilda Bastien with her update on next generation vaccines and where they’re at (news is good but more study needs doing).
The second a review from the Center for Infectious Disease Research and Policy on the latest news on metformin, an drug we’ve been using for many decades for type 2 diabetes, and how a two week course of it appears to reduce the risk of developing long COVID if taken during an active infection.
And while the metformin news is certainly welcome, at least here in Ontario it’s been announced the the government will no longer be distributing free rapid test kits. The thing about medications like metformin and paxlovid that help to prevent long COVID? You need to know you have COVID to take them and without rapid testing or readily available PCR testing, you’re simply not going to know.
Have a great weekend!
This metformin study is interesting. Would be curious, then, if metformin created a protective effect for diabetic patients already taking it, although would then query rate of lactic acidosis (SADMANS) in that population....